Categories 2023 Press Releases Farmacosmo: Ricavi Pro-Forma 2022 Pari A 76 MLN (+31% YoY) Continua La Crescita Di Farmacosmo Ricavi Pari A 63,4 MLN In Crescita Del 10% YoY Post author By Paolo Cimmino Post date 13 February 2023 Farmacosmo: Ricavi Pro-Forma 2022 Pari A 76 MLN (+31% YoY) Continua La Crescita Di Farmacosmo Ricavi Pari A 63,4 MLN In Crescita Del 10% YoY
Categories 2023 Press Releases Farmacosmo: 2022 Pro-Forma Revenue At 76 Mln (+31% Yoy) The Growth Of Farmacosmo Continues Revenues Of 63,4 Million Up By C. 10% Yoy Post author By Antonio Buono Post date 13 February 2023 Farmacosmo: 2022 Pro-Forma Revenue At 76 Mln (+31% Yoy) The Growth Of Farmacosmo Continues Revenues Of 63,4 Million Up By C. 10% Yoy
Categories 2023 Press Releases Closing Per L’acquisizione Del Portale Bau Cosmesi Ad Esito Dell’operazione Farmacosmo Deterrà Il 67% Della Societa’ Proprietaria Del Portale Post author By Paolo Cimmino Post date 2 February 2023 Closing Per L’acquisizione Del Portale Bau Cosmesi Ad Esito Dell’operazione Farmacosmo Deterrà Il 67% Della Societa’ Proprietaria Del Portale
Categories 2023 Press Releases Closing For The Acquisition Of Bau Cosmesi Portal After The Operation Farmacosmo Will Detain 67% Of The Company Owner Of The Portal Post author By Antonio Buono Post date 2 February 2023 Closing For The Acquisition Of Bau Cosmesi Portal After The Operation Farmacosmo Will Detain 67% Of The Company Owner Of The Portal
Categories 2023 Press Releases Risultati Del Primo Periodo Di Esercizio Dei Warrant Farmacosmo 2022-2025 Post author By Paolo Cimmino Post date 31 January 2023 Risultati Del Primo Periodo Di Esercizio Dei Warrant Farmacosmo 2022-2025
Categories 2023 Press Releases “Farmacosmo Warrants 2022-2025” Exercise Period Results Post author By Antonio Buono Post date 31 January 2023 “Farmacosmo Warrants 2022-2025” Exercise Period Results
Categories 2023 Press Releases APPROVATO IL CALENDARIO DEGLI EVENTI SOCIETARI 2023 Post author By Paolo Cimmino Post date 30 January 2023 Approvato Il Calendario Degli Eventi Societari 2023
Categories 2023 Press Releases The Board Of Directors Approves The Corporate Events Calendar 2023 Post author By Antonio Buono Post date 30 January 2023 The Board Of Directors Approves The Corporate Events Calendar 2023
Categories 2023 Press Releases In Corso Primo Periodo Esercizio Warrant Post author By Paolo Cimmino Post date 17 January 2023 In Corso Primo Periodo Esercizio Warrant
Categories 2023 Press Releases Underway First Warrant Exercise Period Post author By Antonio Buono Post date 17 January 2023 Underway First Warrant Exercise Period
Farmacosmo InvestorsFarmacosmo Investors